A recent study indicates that individuals who discontinue new GLP-1 drugs like Mounjaro or Wegovy can put back on lost weight far faster than those who halt conventional diet and exercise regimens.
Findings released in a leading medical journal demonstrates that while overweight people often shed a large proportion of their body weight while on the medication, the weight is regained at an estimated rate of 0.8 kg per month once they quit.
"People purchasing such treatments must be informed of the risk of fast weight regain when the medication is stopped," cautioned researcher Dr. Susan Jebb.
This pace of regain implies a reversion to starting mass in about 18 months.
Comparing Approaches
The study, which looked at dozens of studies involving thousands of patients, compared the results of the injectable medications with older methods.
Scientists note that people who shed pounds through dieting usually see a less rapid weight regain—perhaps 0.1 kg a month—post-intervention.
The Reason for the Quick Rebound
Experts believe the mechanism of the injections is key to understanding the heightened weight return.
These medications mimic a natural hormone called GLP-1, which moderates appetite.
"Long-term administration of GLP-1 concentrations several times higher than normal could lead to the body to produce less of its own natural hormone, and may also diminish sensitivity to its actions," explained Dr. Adam Collins, a nutrition researcher.
"Stopping of this medication means appetite is no longer kept in check, making overeating far more likely."
A Lifelong Disease?
Health authorities advise the jabs for individuals with obesity-related medical conditions, alongside prescribed diet and exercise modifications.
Professionals argue that, due to the likelihood of relapse, the treatment should be considered life-long.
This opinion is echoed by pharmaceutical companies, who state that the findings "emphasize the chronic nature of excess weight," akin to managing diseases like diabetes.
User Testimonies
Individuals who have discontinued the medication describe a sudden return of cravings.
"It was like something that goes on and you become starving," said an individual.
This challenge is worsened if users have not adopted sustainable lifestyle or habit modifications during therapy.
Widespread Use
Survey data suggest that millions of adults in the UK have used weight-loss jabs in the last 12 months, with demand continuing to grow.
- Adoption is greater among women compared to men.
- The 40s and 50s age group shows the highest usage rates.
- A large proportion access the medications through private healthcare rather than public health services.
In conclusion, clinicians emphasize that while GLP-1 drugs are potent tools for weight loss, they are not a magic solution and lasting health benefits relies on integrated lifestyle changes.
